5 Min Read
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks opened little changed on Thursday as a positive read on the labor market was not enough to entice buyers even after a sharp decline in the previous session. The Dow Jones industrial average was down 0.08 percent at 16,791.44 and the S&P 500 was up 0.03 percent at 1,946.8.
** ESPERION THERAPEUTICS INC, $28.17, +15.36 pct
The drugmaker said an experimental cholesterol-fighting drug being developed by the company lowered LDL levels significantly more than Merck & Co Inc's Zetia in a midstage clinical trial.
** REALD INC, $11.6, +25.13 pct
Activist investor Starboard Value LP proposed to take the 3D technology licensor private for $12 per share. The offer represents a premium of 29 percent to RealD stock's Wednesday close of $9.27, valuing the company at about $540 million.
** TESLA MOTORS INC, $248.41, +3.40 pct
The electric car maker's chief executive, Elon Musk, sent out a cryptic tweet on Wednesday, saying it is "about time to unveil the D and something else", with an accompanying photo which mentioned a date, Oct. 9.
** HEAT BIOLOGICS INC, $6.6, +6.80 pct
The drug developer said it completed enrollment of patients for an early-stage study of its bladder cancer treatment, Vesigenurtacel-L. The company said it expects to start mid-stage study for the drug in the fourth quarter.
** TWITTER INC, $51.26, +2.40 pct
JP Morgan raised the microblogging website company's stock to "overweight" from "neutral" and increased its price target to $64 from $54. "Twitter is a primary beneficiary of the shift toward mobile advertising," JP Morgan analyst Doug Anmuth wrote in a note.
** ARIAD PHARMACEUTICALS INC, $5.9504, +12.70 pct
The drug developer said its experimental lung cancer drug received "breakthrough therapy" status from the U.S. Food and Drug Administration.
** FACEBOOK INC, $76.98, +0.56 pct
Facebook said it would change its policy requiring users to go by their real names on the social network, following outrage over the locking of hundreds of accounts, including a number belonging to drag queens using their stage names.
** SEARS HOLDINGS CORP, $26.5, +5.24 pct
Sears Holdings said it would sell most of its stake in Sears Canada Inc through a rights issue that would raise up to $380 million ahead of the holiday season.
** JPMORGAN CHASE & CO, $59.36, -0.02 pct
UBS Investment Research downgraded the bank's stock to "neutral" from "buy". Lower loan growth, "nearly insatiable appetite for fines by regulators," and increasing capital requirements will pinch the bank, UBS analyst Brennan Hawken wrote in a note to clients.
** DISH NETWORK CORP, $63.2, -0.63 pct
** VERIZON COMMUNICATIONS INC, $49.45, +0.04 pct
** AT&T INC, $34.97, +0.03 pct
** T-MOBILE US INC, $28.09, -0.07 pct
Three of the four largest U.S. wireless carriers and satellite provider Dish Network plan to bid in the Federal Communications Commission's November auction of airwaves, according to initial applications released on Wednesday. The largest U.S. wireless carrier Verizon Communications, AT&T Inc, T-Mobile US and Dish appeared to be the largest companies to indicate an interest in bidding in the upcoming auction of frequencies known as AWS-3.
** WILAN INC, $3.19, -9.16 pct
The Canadian patent licensing company on Wednesday said a U.S. judge had ruled in favor of Apple Inc in a litigation case against it.
** MASIMO CORP, $22.75, -5.29 pct
The Dutch healthcare equipment company Philips said on Thursday it would appeal against a U.S court ruling ordering it to pay $466.8 million in compensation to Masimo for infringing two patents.
** DIRECTV, $87.61, +1.18 pct
The U.S. satellite TV provider extended its exclusive contract to sell the Sunday Ticket package of National Football League games, and sources said the company will pay $1.5 billion a year to keep the popular offering that has helped attract subscribers.
** NEWLINK GENETICS CORP, $22.11, -3.66 pct
The drug developer appointed Jack Henneman, former chief financial officer of Integra Lifesciences Holdings Corp , its executive vice president and CFO. (Compiled by Anannya Pramanick; Editing by Maju Samuel)